10x Genomics to Report Second Quarter Financial Results on August 4, 2021

Rhea-AI Summary

10x Genomics (Nasdaq: TXG) will report its Q2 2021 financial results on August 4, 2021, after market close. A conference call will follow at 1:30 p.m. PT to discuss the results and company outlook. The event will be accessible via live webcast, archived for 45 days. 10x Genomics focuses on technologies for biological analysis, with a portfolio of over 1,100 patents and products used by top global research institutions and pharmaceutical companies. The company emphasizes its commitment to advancing human health through innovative solutions.

Positive

• 10x Genomics will report Q2 2021 financial results, providing insights into performance.
• The company has a robust patent portfolio with over 1,100 patents.
• The products are widely adopted by leading global research institutions and pharmaceutical companies.

Negative

• None.

PLEASANTON, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the second quarter 2021 after market close on Wednesday, August 4th, 2021. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics
10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2019 based on publications and all of the top 20 global pharmaceutical companies by 2019 research and development spend, and have been cited in over 2,500 research papers on discoveries ranging from oncology to immunology and neuroscience. The company’s patent portfolio comprises more than 1,100 issued patents and patent applications.
  
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts
Media:
media@10xgenomics.com

Investors:
investors@10xgenomics.com

FAQ

When will 10x Genomics report its Q2 2021 financial results?

10x Genomics will report its Q2 2021 financial results on August 4, 2021, after market close.

What time is the conference call for 10x Genomics Q2 2021 results?

The conference call will take place at 1:30 PM Pacific Time on August 4, 2021.

How can I access the webcast for 10x Genomics financial results?

The webcast will be available on the 'Investors' section of the 10x Genomics website.

What is the significance of the 10x Genomics patent portfolio?

10x Genomics has a patent portfolio of over 1,100 patents, which supports its innovative technology in life sciences.